Patents by Inventor Barbara Brewitt

Barbara Brewitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060088575
    Abstract: A preparation comprising a homeopathic potency of a purified composition, such as insulin-like growth factor, insulin-like growth factor-1 (IGF-1), growth hormone, transforming growth factor (TGF), TGF?1, fibroblast growth factor (FGF), FGF1, FGF2, GM-CSF, M-CSF, PDGF??, nerve growth factor (NGF) and epidermal growth factor (EGF), is provided. The concentration of the purified composition is less than 1×106 molar and the homeopathic potency is formulated in a generally solid, food-based or a generally liquid beverage carrier.
    Type: Application
    Filed: October 4, 2005
    Publication date: April 27, 2006
    Inventor: Barbara Brewitt
  • Patent number: 5629286
    Abstract: The present invention comprises homeopathic dilutions of growth factors and methods for their use. Disorders which may be effectively treated with the compositions of the present invention include chronic viral disorders, such as HIV, AIDS, chronic fatigue syndrome and Epstein-Barr viral infections, cancer and diabetes. Homeopathic dilutions of growth factors are preferably administered orally. In an alternative embodiment, patients are treated with radio frequency signals corresponding to homeopathic dilutions of growth factors.
    Type: Grant
    Filed: September 10, 1996
    Date of Patent: May 13, 1997
    Inventor: Barbara Brewitt
  • Patent number: 5626617
    Abstract: The present invention comprises homeopathic dilutions of growth factors and methods for their use. Disorders which may be effectively treated with the compositions of the present invention include chronic viral disorders, such as HIV, AIDS, chronic fatigue syndrome and Epstein-Barr viral infections, cancer and diabetes. Homeopathic dilutions of growth factors are preferably administered orally. In an alternative embodiment, patients are treated with electromagnetic signals, preferably radiofrequency signals, corresponding to homeopathic dilutions of growth factors.
    Type: Grant
    Filed: December 20, 1995
    Date of Patent: May 6, 1997
    Inventor: Barbara Brewitt